Dioscin elicits anti-tumour immunity by inhibiting macrophage M2 polarization via JNK and STAT3 pathways in lung cancer.

In conclusion, dioscin may act as a new anti-tumour agent by inhibiting TAMs via JNK and STAT3 pathways in lung cancer.
PMID: 32618105 [PubMed - as supplied by publisher]

Source: J Cell Mol Med - July 1, 2020 Category: Molecular Biology Authors: Cui L, Yang G, Ye J, Yao Y, Lu G, Chen J, Fang L, Lu S, Zhou J Tags: J Cell Mol Med Source Type: research